Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGLL | Q99685 | 5/20 | 0.50 |
| ▸ | OPRM1 | P35372 | 4/20 | 0.50 |
| ▸ | OPRD1 | P41143 | 4/20 | 0.50 |
| ▸ | OPRK1 | P41145 | 4/20 | 0.50 |
| ▸ | FAAH | O00519 | 3/20 | 0.50 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.48 |
| ▸ | TLR9 | Q9NR96 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | TP53 | P04637 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 1/20 | 0.48 |
| ▸ | PKM | P14618 | 1/20 | 0.48 |
| ▸ | HPGD | P15428 | 1/20 | 0.48 |
| ▸ | XBP1 | P17861 | 1/20 | 0.48 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.48 |
| ▸ | HTT | P42858 | 1/20 | 0.48 |
| ▸ | RECQL | P46063 | 1/20 | 0.48 |
| ▸ | RAB9A | P51151 | 1/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.48 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13865204 | 0.89 | OPRM1 (0.43) | MGLLOPRM1OPRD1OPRK1FAAH | |
| SCHEMBL17740045 | 0.85 | PTGS1 (0.53) | MGLLOPRM1OPRD1OPRK1FAAH | |
| SCHEMBL19703580 | 0.83 | MGLL (0.61) | MGLLOPRM1OPRD1OPRK1FAAH | |
| SCHEMBL19698122 | 0.81 | OPRM1 (0.49) | MGLLOPRM1OPRD1OPRK1FAAH | |
| SCHEMBL3794652 | 0.80 | MGLL (0.56) | MGLLOPRM1OPRD1OPRK1FAAH | |
| SCHEMBL3270615 | 0.80 | MGLL (0.56) | MGLLOPRM1OPRD1OPRK1FAAH | |
| SCHEMBL19704564 | 0.80 | PTGS1 (0.56) | MGLLOPRM1OPRD1OPRK1FAAH | |
| SCHEMBL19703879 | 0.80 | PTGS1 (0.66) | MGLLOPRM1OPRD1OPRK1FAAH | |
| SCHEMBL19698144 | 0.80 | OPRM1 (0.48) | MGLLOPRM1OPRD1OPRK1FAAH | |
| SCHEMBL13310414 | 0.79 | MGLL (0.50) | MGLLOPRM1OPRD1OPRK1FAAH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10890532-B2 | Compositions and methods for performing assays | PALO ALTO RESEARCH CENTER INCORPORATED (US) | 2021-01-12 | — | — | US | disclosed |
| US-8034928-B2 | Fluorescence assays with improved sensitivity | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2011-10-11 | — | — | US | disclosed |
| US-8034928-B2 | Fluorescence assays with improved sensitivity | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2011-10-11 | — | — | US | disclosed |
| US-20090299061-A1 | FLUORESCENCE ASSAYS WITH IMPROVED SENSITIVITY | PENN STATE RESEARCH FOUNDATION | 2009-12-03 | — | — | US | disclosed |
| US-20090299061-A1 | FLUORESCENCE ASSAYS WITH IMPROVED SENSITIVITY | PENN STATE RESEARCH FOUNDATION | 2009-12-03 | — | — | US | disclosed |
| US-7534902-B2 | Fluorescence assays with improved sensitivity | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2009-05-19 | — | — | US | disclosed |
| US-7534902-B2 | Fluorescence assays with improved sensitivity | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2009-05-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090299061-A1 | FLUORESCENCE ASSAYS WITH IMPROVED SENSITIVITY | UACA, HNRNPUL1, FUS | MGLL 2129/4885OPRM1 2903/4885OPRD1 4362/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.